Welcome to Francis Academic Press
Login | Register

International Journal of Frontiers in Medicine, 2022, 4(8); doi: 10.25236/IJFM.2022.040803.

Research Progress of Radiotherapy for Nasopharyngeal Carcinoma

Author(s)

Anqi Zhang, Lei Gao, Xiaoyan Shi, Wenyi Kang

Corresponding Author:
Lei Gao
Affiliation(s)

The First Affiliated Hospital of Yangtze University, Jingzhou, China

Abstract

Nasopharyngeal carcinoma (NPC) is a common head and neck malignant tumor. Radiotherapy can effectively improve the tumor control rate because of its sensitivity to radiation. With the continuous update of radiotherapy technology, on the basis of conventional fractionated radiotherapy, unconventional fractionated radiotherapy, 3D conformal radiotherapy (3DCRT), intensity modulated conformal radiotherapy (IMRT), volume arc intensity modulated radiotherapy (VMAT) and other methods have been developed. In this paper, the research progress of radiotherapy for nasopharyngeal carcinoma was briefly reviewed.

Keywords

Nasopharyngeal Carcinoma, Conventional Radiotherapy Three-Dimensional Conformal Radiotherapy, Intensity Modulated Radiotherapy, Volume Arc Intensity Modulated Radiotherapy

Cite This Paper

Anqi Zhang, Lei Gao, Xiaoyan Shi, Wenyi Kang. Research Progress of Radiotherapy for Nasopharyngeal Carcinoma. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 8: 10-12. https://doi.org/10.25236/IJFM.2022.040803.

References

[1] Chen, Y.P., et al., Nasopharyngeal carcinoma. Lancet, 2019. 394(10192): p. 64-80.

[2] Chang, Y., et al., Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci, 2020. 24(11): p. 6409-6416.

[3] Wu Lizhi and Chen Shiming, Research progress on the mechanism of radiotherapy resistance in nasopharyngeal carcinoma. Shandong Medicine, 2020. 60(12): p. 102-105.

[4] Kang Min, Chinese guidelines for radiotherapy of nasopharyngeal carcinoma (2020 edition). Chinese Journal of Cancer Prevention and Treatment, 2021. 28(03): p. 167-177.

[5] Ren Shuhui, Analysis of the efficacy of three-dimensional conformal radiation therapy for nasopharyngeal carcinoma. Chinese Medicine and Clinical Medicine, 2021. 21(04): p. 629-631.

[6] Lee, A.W.M., et al., Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev, 2019. 79: p. 101890.

[7] Li Geng, Progress in comprehensive treatment of locally advanced nasopharyngeal carcinoma. Chinese and Foreign Medical Research, 2020. 18(11): p. 172-174.

[8] Yang Baoqing, Current status and progress in the treatment of locally advanced nasopharyngeal carcinoma. Modern Oncology, 2021. 29(02): p. 337-341.

[9] Zhang Pan, Zhang Di, and Dai Xiaobo, Research progress of re-radiation therapy for recurrent nasopharyngeal carcinoma. Journal of Practical Oncology, 2019. 33(01): p. 92-96.

[10] Lee, H.M., et al., Current Perspectives on Nasopharyngeal Carcinoma. Adv Exp Med Biol, 2019. 1164: p. 11-34.

[11] Sun, X.S., et al., Future of Radiotherapy in Nasopharyngeal Carcinoma. Br J Radiol, 2019. 92(1102): p. 20190209.

[12] You, R., et al., Efficacy and Safety of Locoregional Radiotherapy with Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial. JAMA Oncol, 2020. 6(9): p. 1345-1352.

[13] Lu Haijun, Liu Ji, and Ding Xiao, Research progress of comprehensive treatment of nasopharyngeal carcinoma. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019. 33(02): p. 26-30.